Animal Health Solution - a Henry Schein Animal Health magazine for veterinary professionals
Issue link: https://www.e-digitaleditions.com/i/1503908
(fluralaner) Chews IMPORTANT SAFETY INFORMATION: BRAVECTO (fluralaner) Chews for Dogs: The most commonly reported adverse reactions include vomiting, lethargy, diarrhea, anorexia and pruritus. In some cases, adverse events have been reported following use in breeding females. BRAVECTO Chews has not been shown to be effective for 12-weeks' duration in puppies less than 6 months of age. BRAVECTO Chews is not effective against lone star ticks beyond 8 weeks of dosing. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Please see full product information on [page xx]. Copyright © 2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved. US-BRV-221000015 721759 * Compared to monthly products. † BRAVECTO (fluralaner) Chews for Dogs kills fleas, prevents flea infestations, and kills ticks (black-legged tick, American dog tick, brown dog tick, and Asian longhorned tick) for 12 weeks. BRAVECTO Chews also kills lone star ticks for 8 weeks. Reference: 1. BRAVECTO® Chews [product label]. Madison, NJ: Merck Animal Health; 2022. more chasing squirrels, more m eet a n d g r ee t s , m ore c a r r i d e s , M o r e ra c e s t hro u g h t h e park, Mo re b i r d Talk to your Merck Animal Health representative to learn more. us.bravecto.com PROTECTION THAT GOES LOOONG We know compliance can be tough for clients. That's why a single dose of BRAVECTO® Chews lasts nearly 3x longer than a single dose of monthly flea and tick products. 1 Give your clients less to worry about and your patients more between doses.* IMPORTANT SAFETY INFORMATION: BRAVECTO (fluralaner) Chews for Dogs: The most commonly reported adverse reactions include vomiting, lethargy, diarrhea, anorexia and pruritus. In some cases, adverse events have been reported following use in breeding females. BRAVECTO Chews has not been shown to be effective for 12-weeks' duration in puppies less than 6 months of age. BRAVECTO Chews is not effective against lone star ticks beyond 8 weeks of dosing. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Please see full product information on Reference: 1. BRAVECTO® Chews [product label]. Madison, NJ: Merck Animal Health; 2022. e t s , m ore c a r r i d e s , M o r e ra c e s t hro u g h t h t h t e park, Mo re b i r d more chasing squirrels, more m eet a n a n a d g r ee t Talk to your Merck Animal Health representative to learn more. us.bravecto.com THAT GOES LOOONG We know compliance can be tough for clients. That's why a single dose of BRAVECTO® Chews lasts nearly 3x longer than a single dose of monthly flea and tick products. 1 Give your clients less to worry about and your patients more between doses.* page 20. page 20.